← Back to patent-cliff list
Nitisinone
Tier C — Watch / tradeNitisinone
Swedish Orphan Biovitrum Ag
Originator
2002
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：4HPPD
Brand：HARLIKU, Orfadin, Nityr
Indications (approved)：黑尿症, 酪氨酸血症
Regional status
US
Approved
2002-01-18
EU
Approved
2005-02-20
China
Approved
2021-06-16
Japan
Approved
2014-12-26
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Nitisinone?
Approved indications include: 黑尿症, 酪氨酸血症.
When does the Nitisinone patent expire?
No public expiry year is available for Nitisinone yet; this page updates once verified.
How do I get a quote for Nitisinone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27